Cited by 135Retinal Development and DisordersRetinal Diseases and TreatmentsRetinoids in leukemia and cellular processes

Primary amines protect against retinal degeneration in mouse models of retinopathies

Open access
Maeda, Akiko, Golczak, Marcin, Chen, Yu, Okano, Kiichiro, Kohno, Hideo, Shiose, Satomi, Ishikawa, Kaede, Harte, William +3 more·2012·Nature Chemical Biology

Abstract

Vertebrate vision is initiated by photoisomerization of the visual pigment chromophore 11-cis-retinal and is maintained by continuous regeneration of this retinoid through a series of reactions termed the retinoid cycle. However, toxic side reaction products, especially those involving reactive aldehyde groups of the photoisomerized product, all-trans-retinal, can cause severe retinal pathology. Here we lowered peak concentrations of free all-trans-retinal with primary amine-containing Food and Drug Administration (FDA)-approved drugs that did not inhibit chromophore regeneration in mouse models of retinal degeneration. Schiff base adducts between all-trans-retinal and these amines were identified by MS. Adducts were observed in mouse eyes only when an experimental drug protected the retina from degeneration in both short-term and long-term treatment experiments. This study demonstrates a molecular basis of all-trans-retinal-induced retinal pathology and identifies an assemblage of FDA-approved compounds with protective effects against this pathology in a mouse model that shows features of Stargardt's disease and age-related retinal degeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nchembio.759

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Retinylamine and other primary amines buffer the toxic effect of all-trans-retinal by inhibiting the visual cycle or by chemically trapping excess all-trans-retinal as a Schiff base when it cannot be cleared by reduction to all-trans-retinol.

    “Retinylamine and other primary amines were employed to buffer the toxic effect of all-trans-retinal either by inhibiting the visual cycle or by chemically trapping an excess of all-trans-retinal in the form of a Schiff base when it could not be effectively cleared from photoreceptor cells by reduction to all-trans-retinol (Figure 36).318,572,573”

    From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [572]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maeda, A., Golczak, M., Chen, Y., Okano, K., Kohno, H., Shiose, S., Ishikawa, K., Harte, W., Palczewska, G., Maeda, T., & Palczewski, K.
Affiliations
  • Case Western Reserve University (US)
  • Polgenix (United States) (US)
Corresponding author
Palczewski, Krzysztof
Venue
Nature Chemical Biology
Published
2011-12-25
Volume
8
Issue
2
Pages
170-178
ISSN
  • 1552-4450 (ISSN-L)
  • 1552-4469
OpenAlex
W2004577874
Cited by
135
References
51
Citations by year
2026: 2 · 2025: 5 · 2024: 4 · 2023: 7 · 2022: 3 · 2021: 12 · 2020: 12 · 2019: 5 · 2018: 13 · 2017: 8 · 2016: 12 · 2015: 13 · 2014: 16 · 2013: 14 · 2012: 8
FWCI
5.06
Type
journal article
Language
en
Open access
Locations
  • Nature Chemical Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Eye Institute (EY021126, K08EY019880, EY019880, EY009339, K08EY019031, R24EY021126, EY019031, P30 EY-11373, P30EY011373, R01EY009339)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
primary amines, retinal degeneration, Stargardt disease, age-related retinal degeneration, all-trans-retinal, Schiff base adducts, retinoid cycle, 11-cis-retinal regeneration, lipofuscin, FDA-approved drugs, drug repurposing
MeSH terms
Amines, Animals, Disease Models, Animal, Dose-Response Relationship, Drug, Macular Degeneration, Retinal Degeneration, Retinaldehyde, Schiff Bases, United States, United States Food and Drug Administration, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review